Pharmaceuticals

Johnson and Johnson says that their booster shot provides enhanced COVID-19 protection

The latest trial results of the pharmaceutical company show that persons receiving a Johnson & Johnson COVID-19 vaccine booster shot…

3 years ago

Govt To Amend Schedule K Of Drugs Rules 1945 To Exempt Antiseptics From Sale License

The Ministry of Health and Family Welfare (MoHFW) has issued draught rules proposing that the retail sale of liquid antiseptics…

3 years ago

Pfizer Covid-19 booster for sixty-five and up is rejected by US FDA panel

A panel of expert advisers to the US Food and Drug Administration, rejecting a demand for wider distribution, said the…

3 years ago

Glenmark completes Favipiravir (FabiFlu®) after-marketing surveillance in 1000+ COVID-19 patients

Glenmark Pharmaceuticals has announced today the successful conclusion of its Favipiravir (FabiFlu®) post marketing surveillance (PMS) in India study, which…

3 years ago

BDR Pharma develops medicines against cancer cell replication

Mumbai: BDR Pharma, a generic company, announces that Cabozantinib can be launched, which can treat metastatic meduller thyroid, advanced renal…

3 years ago

According to USFDA enforcement notice, drug manufacturers Granules India and Jubilant Cadista are recalling goods in US market

Granules India and Jubilant Cadista, two generic medication manufacturers, are recalling a variety of goods in the United States, the…

3 years ago

Zydus Cadila seeks approval of its approved tri-dose COVID-19 vaccine in India for two dose regimen

New Delhi: Taking into consideration the burden for the healthcare system and the costs associated with three doses, Zydus Cadila…

3 years ago

USFDA Nod for Zydus Cadila for the treatment of schizophrenia

Drug company Zydus Cadila announced on Thursday that Brexpiprazole tablets, used for the treatment of Schizophrenia, have received market approval…

3 years ago

U.S. FDA approval for sitagliptin base for Zydus Cadilla Arm

Zydus Cadila, one of the leading Indian pharmaceutical companies, announced its tentative approval for its new sitagliptin bases 25, 50…

3 years ago

Zydus Cadila receives USFDA nod for diabetes medicines

The US health authorities approved Sitagliptin for marketing, which was recommended to treat diabetes, on Monday, Drug company Zydus Cadila…

3 years ago